Search Results

deny coverage for individuals at risk. Patients, physicians, and advocacy groups have identified breast MRI in carriers of HBOC and colonoscopies for younger individuals with Lynch syndrome as the most difficult services to obtain. 2 , 3 Difficulty in

, and pelvis (see PBCL-3 , page 1270). FDG-PET/CT or FDG-PET/MRI is recommended if available. 25 However, treatment should not be delayed to obtain this scan, and FDG-PET does not exclude the need for full diagnostic quality, high-resolution CT or MRI

, contrast-enhanced CT or MRI scan is sometimes used as a surveillance test in high-risk individuals. 8 The American Association for the Study of Liver Diseases (AASLD) endorsed an HCC surveillance program for high-risk patients with its first HCC practice

day 1 of first-line treatment. Specifically, we examined (1) imaging modality used (chest/abdomen/pelvis CT, bone scan, 18 F-fluorodeoxyglucose [FDG]-PET/PET-CT, abdominal MRI, abdominal ultrasound, chest radiograph, spine MRI, head CT, brain MRI); (2

://www.survivorshipguidelines.org/ . Accessed July 19, 2007 . 11. Saslow D Boetes C Burke W . American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography . CA Cancer J Clin 2007 ; 57 : 75 – 89 . 12. Gail MH Brinton LA Byar DP

, lowering the imaging sensitivity for these findings. Cross-sectional imaging with either a CT scan or an MRI evaluates the local disease burden and assesses for nodal and distant metastases. The accuracy of CT and an MRI for staging the local extent of

examples of this use in breast cancer imaging, including MRI enhancement characteristics with specific tumor molecular subtypes or imaging with targeted monoclonal antibodies linked to PET agents to more clearly elucidate specific tumor expression, 10 in

fractionation schemes. The survival advantage of PCI was recently challenged by a randomized phase III Japanese trial of 224 patients with extensive-stage SCLC. 25 Patients were required to have an MRI before PCI to confirm the absence of brain metastases and

clinical response signals in a broad array of solid tumors Evaluate whether dynamic contrast-enhanced MRI, to determine the degree of vascular permeability, and PET scan, to delineate tumor viability and glucose uptake, are able to predict major

fluorodeoxyglucose uptake in the right upper lobe mass and the right hilar and subcarinal regions. MRI of the brain in February 2010 was negative. She underwent an endobronchial ultrasound biopsy of a subcarinal node, which was positive for adenocarcinoma. Concurrent